Colorado cannabis labels overstate THC content, raising consumer concerns

Commercial cannabis product testing: Fidelity to labels and regulations.

PloS one • • Moderately Relevant
🤖

AI Summary

Colorado cannabis product labels frequently overstate THC concentrations compared to actual tested content, according to an analysis of 74 samples from licensed Denver-area dispensaries. The study found that flower and edible products had significantly higher label claims than observed values, while concentrates showed no significant difference. This discrepancy is especially concerning for flower products, which fell outside the 15% legally allowable variation range, suggesting labeling practices may not align with regulatory standards.

These findings highlight a critical gap between what consumers expect to purchase based on labels and what they actually receive. Since consumers make purchasing decisions based on labeled THC concentrations, inaccurate labeling could lead to unexpected effects—too little for medical patients needing therapeutic doses, or too much for casual users seeking controlled experiences. The variation appears dependent on product type, with flower products showing the most problematic discrepancies, indicating that different cannabis formats may require tailored testing and labeling standards.

As the legal cannabis market continues to evolve, the research underscores an urgent need for stricter regulations and more rigorous testing protocols to ensure label accuracy. Without standardized practices that hold manufacturers accountable, consumers lack reliable information to make informed purchasing decisions, and the credibility of the legal cannabis industry is undermined by the mismatch between advertised and actual potency.

📄 Original Abstract

In Colorado, regulations for recreational and medical cannabis sales require tetrahydrocannabinol (THC) concentration is printed on all products. Labeled THC concentrations can vary by +/-15% of what is in the product. Studies show THC concentrations recorded on product labels are not always reflective of the THC concentration in the cannabis product and there is evidence consumers make purchasing decisions based on label claims. Explore the accuracy of cannabis product labels and differences between THC label accuracy and product type. Data for this analysis come from a larger observational study of cannabis impairment. N = 74 flower, concentrate, and edible product samples from licensed Colorado dispensaries were collected and independently tested for THC concentration. This study was conducted in Colorado, in the Denver Metro Area. Participants in the study voluntarily enrolled and provided one-gram samples of the cannabis they consumed during the study to be independently tested. The cannabis tested for this analysis was donated on a voluntary basis, not all participants chose to donate. The main outcomes of interest for this analysis are accuracy of cannabis product labels compared to observed THC content, accuracy in the context of legally allowable variation, and difference between accuracy by product. Overall, label values were higher than observed values in flower and edible products (p < 0.001) but was not significant for concentrates (p = 0.85). Flower products were observed to be significantly lower on labels versus the 15% legally allowable range (p = 0.04). Concentrate and edible products were not significantly different (p = 0.9 and p = 0.5, respectively). There is tension between legally allowable THC concentration claims on cannabis product labels and how consumers purchase cannabis. As cannabis policy evolves, standards and regulations that ensure accurate THC concentrations are reported on product labels are urgently needed.

Explore More Research

Stay informed about the latest cannabis science.

Your stash, decoded.